Research Papers Published
- "Pathological implications of Cx43 down-regulation in human colon cancer." Asian Pac J Cancer Prev, 15(7): 2987 -2991 Impact Factor= 1.5
- "Internal ribosomal entry site (IRES) activity generates endogenous carboxyl-terminal domains of Cx43 and is responsive to hypoxic conditions" JBC, 289(30): 20979 -20990 Impact Factor= 4.6
- "Protein kinase C (PKC) mediated interaction between conexin43 (Cx43) and K(+)(ATP) channel subunit (Kir6.1) in cardiomyocyte mitochondria: Implications in cytoprotection against hypoxia induced cell apoptosis" Cellular signalling, 26(9): 1909 -1917 Impact Factor= 4.471
- "MicroRNAs and human diseases: diagnostic and therapeutic potential." Cell Tissue Res, 358(1): 1 -15 Impact Factor= 3.333
- "The carboxy-terminal domain of connexin 43 (CT-Cx43) modulates the expression of p53 by altering miR-125b expression in low-grade human breast cancers." Cell Oncol, 38(6): 443 -451 Impact Factor=
- "Research" Biochemical journal, 473(20): Pub Med ID. 3597 {ISSN: 0264-6021} Impact Factor= 3.57
- "Connexin 43 and ATP-sensitive potassium channels crosstalk: a missing link in hypoxia/ischemia stress." cell and tissue research, 371(2): 213 -222 Impact Factor=
- "Triose-phosphate isomerase is a novel target of miR-22 and miR-28, with implications in tumorigenesis." J Cell Physiol., 20(1): DOI No. 10.1002/jcp.26821. Impact Factor=
- "Role of GW182 protein in the cell." Int J Biochem Cell Biol, 101(2): 29 -38 Impact Factor=
Books Published
- "DNA Recombinant Technology and Molecular techniques". Black Prints, New Delhi. {ISBN: 978-93-82036-73-9} pp 124
- "Connexins: The Gap Junctions Proteins". Springer. {ISBN: 978-81-322-1918-7} pp 93
- "Biotechnology Laboratory Manual". Black Prints, New Delhi. {ISBN: 978-93-82036-29-6} pp 140
Research Projects Details:
| Title of the Project | Funding Agency | Dated | Amount (in Rs.) |
|---|
| Internal ribosome Entry site (IRES) mediated expression of endogenously produced carboxy-
terminal domain of connexin 43 (CT-Cx43): Status of expression in the breast cancer | Department of Biotechnology, New Delhi | | 2,730,000.00 |
| Increased glycolytic capacity of Astrocytes during
hypoxia: Role of the cap-independent Translational of
glycolytic enzymes | DBT, New Delhi | 11-10-2014 | 4,629,000.00 |
| Internal ribosome Entry site (IRES)mediated expression of endogenously produced carboxy terminal domain of connexin 43: status of expression in the breast cancer | DBT, New Delhi | 03-03-2014 | 2,730,000.00 |
| Expressions dynamics of TP53 and its isoforms during hypoxia: Role of hypoxia-regulated microRNAs (miRNAs). | DST-New delhi | 20-08-2014 | 4,950,000.00 |
| Up-regulation of pyruvate Kinase M2 in human colorectal cancer: Role of post-transcriptional regulatory elements. | DBT-New delhi | 02-04-2015 | 2,478,000.00 |
| To understand the signal transduction pathway involving the role of adenosine-triphosphate-sensitive K+ channel (kir6.1) and Cx43. | CSIR-New delhi | 03-07-2013 | 2,460,000.00 |
| Expression Dynamics of carboxy-terminal domain of connexin 43 (Cx43) under ischemic stress and its role in ischemia preconditioning | DST-New delhi | 01-01-2018 | 1,573,000.00 |
| Internal ribosome Entry site (IRES) mediated expression of endogenously produced carboxy-terminal domain of connexin 43 (CT-Cx43): Status of expression in the breast cancer | DBT-new delhi | 05-02-2018 | 2,730,000.00 |
| Increased glycolytic capacity of Astrocytes during hypoxia: Role of the cap-independent Translational of glycolytic enzymes | DBT-New Delhi | 02-01-2018 | 4,629,000.00 |
Department of Biotechnology